Exact Mass: 190.0517954
Exact Mass Matches: 190.0517954
Found 213 metabolites which its exact mass value is equals to given mass value 190.0517954
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Carglumic acid
Carglumic acid is an orphan drug used for the treatment of hyperammonaemia in patients with N-acetylglutamate synthase deficiency. This rare genetic disorder results in elevated blood levels of ammonia, which can eventually cross the blood-brain barrier and cause neurologic problems, cerebral edema, coma, and death. Carglumic acid was approved by the U.S. Food and Drug Administration (FDA) on 18 March 2010. A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AA - Amino acids and derivatives C78275 - Agent Affecting Blood or Body Fluid KEIO_ID C078
3-Dehydroquinic acid
3-Dehydroquinic acid belongs to the class of organic compounds known as alpha-hydroxy acids and derivatives. These are organic compounds containing a carboxylic acid substituted with a hydroxyl group on the adjacent carbon. 3-Dehydroquinic acid is an extremely weak basic (essentially neutral) compound (based on its pKa). In most organisms, 3-dehydroquinic acid is synthesized from D-erythrose-4-phosphate in two steps. However, archaea genomes contain no orthologs for the genes that encode these first two steps. Instead, archaeabacteria appear to utilize an alternative pathway in which 3-dehydroquinic acid is synthesized from 6-deoxy-5-ketofructose-1-phosphate and L-aspartate-semialdehyde. These two compounds are first condensed to form 2-amino-3,7-dideoxy-D-threo-hept-6-ulosonate, which cyclizes to 3-dehydroquinic acid. From 3-dehydroquinic acid and on to chorismate, the archaeal pathway appears to be identical to the bacterial pathway. In most organisms, 3-dehydroquinate is synthesized from D-erythrose-4-phosphate in two steps . However, the genomes of the archaea contain no orthologs for the genes that encode these first two steps. Instead, archaeabacteria appear to utilize an alternative pathway in which 3-dehydroquinate is synthesized from 6-deoxy-5-ketofructose-1-phosphate and L-aspartate-semialdehyde . These two compounds are first condensed to form 2-amino-3,7-dideoxy-D-threo-hept-6-ulosonate , which cyclizes to 3-dehydroquinate . From 3-dehydroquinate and on to chorismate , the archaeal pathway appears to be identical to the bacterial pathway [HMDB]. 3-Dehydroquinate is found in many foods, some of which are allium (onion), cashew nut, american cranberry, and common wheat.
L-alpha-Amino-gamma-oxalylaminobutyric acid
A monocarboxylic acid amide obtained by the formal condensation of the amino group at position 4 of L-2,4-diaminobutyric acid with the carboxy group of oxalic acid.
L-beta-aspartyl-L-glycine
L-beta-aspartyl-l-glycine is a proteolytic breakdown product of larger proteins. It belongs to the family of Acyl Glycines. These are organic compounds containing a glycine residue with the N-atom attached to another moiety through an N-ester bond. It is found in urine (PMID: 3782411). A dipeptide found in urine (PMID: 3782411). This is a proteolytic breakdown product of larger proteins. [HMDB]
Aspartyl-Glycine
Aspartyl-Glycine is a dipeptide composed of aspartate and glycine. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
Glycyl-Aspartate
Glycyl-Aspartate is a dipeptide composed of glycine and aspartate. It is an incomplete breakdown product of protein digestion or protein catabolism. Some dipeptides are known to have physiological or cell-signaling effects although most are simply short-lived intermediates on their way to specific amino acid degradation pathways following further proteolysis. This dipeptide has not yet been identified in human tissues or biofluids and so it is classified as an Expected metabolite.
5-(Methylthio)-2-[(methylthio)methyl]-2-pentenal
5-(Methylthio)-2-[(methylthio)methyl]-2-pentenal is found in garden tomato. 5-(Methylthio)-2-[(methylthio)methyl]-2-pentenal is a flavouring ingredient and antioxidant. 5-(Methylthio)-2-[(methylthio)methyl]-2-pentenal is present in tomato juice and hydrolysed vegetable protein. 5-(Methylthio)-2-[(methylthio)methyl]-2-pentenal is a flavouring ingredient and antioxidant. It is found in tomato juice and hydrolysed vegetable protein.
2-Hydroxy-2-(2-oxopropyl)butanedioic acid
2-Hydroxy-2-(2-oxopropyl)butanedioic acid belongs to the family of Medium-chain Keto Acids and Derivatives. These are keto acids with a 6 to 12 carbon atoms long side chain.
N-carbamoylglutamic Acid
N-carbamoylglutamic Acid, also known as N-Carbamoylglutamate, is classified as a glutamic acid or a Glutamic acid derivative. Glutamic acids are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom. N-carbamoylglutamic Acid is considered to be soluble (in water) and acidic
2-O-Methylascorbic acid
2-O-Methylascorbic acid (2-O-MA) is a derivative of vitamin C (ascorbic acid). The enzyme catechol-O-methyltransferase catalyzes the methylation of L-ascorbic acid into 2-O-methylascorbic acid (PMID: 7129800). 2-O-Methylascorbic acid belongs to the class of organic compounds known as butenolides. These are dihydrofurans with a carbonyl group at the C2 carbon atom. 2-O-Methylascorbic acid has been identified in urine and was found to be higher in older women than in younger women (PMID: 28813537).
Asp-gly
A dipeptide composed of L-aspartic acid and glycine joined by a peptide linkage.
Gly-asp
A dipeptide formed from glycyl and L-aspartic acid residues.
FA 7:2;O4
5-FLUORO-2-PYRAZOL-1-YL-BENZALDEHYDE
C10H7FN2O (190.05423839999997)
Thiazolo[4,5-h]isoquinoline, 6,7,8,9-tetrahydro- (9CI)
1-(2-Fluorophenyl)-1H-pyrazole-4-carboxaldehyde
C10H7FN2O (190.05423839999997)
1-(3-Fluorophenyl)-1H-pyrazole-4-carboxaldehyde
C10H7FN2O (190.05423839999997)
(2-MORPHOLIN-4-YLMETHYL-BENZOIMIDAZOL-1-YL)-ACETIC ACID
1-Piperazinecarboxaldehyde, 4-(chloroacetyl)- (9CI)
Benzaldehyde, 3-fluoro-4-(1H-imidazol-1-yl)
C10H7FN2O (190.05423839999997)
4-(4-Methyl-phenyl)-1,3-dihydro-imidazole-2-thione
Boronic acid, (8-fluoro-2-naphthalenyl)- (9CI)
C10H8BFO2 (190.06013500000003)
(2S-CIS)-5-(2-(DIMETHYLAMINO)ETHYL)-2,3-DIHYDRO-3-HYDROXY-2-(4-METHOXYPHENYL)-1,5-BENZOTHIAZEPIN-4(5H)-ONE
4-amino-1-methyl-1h-pyrrole-2-carboxylic acid-methyl ester hcl
(3S-CIS)-(-)-3-PHENYLTETRAHYDROPYRROLO-[2,1-B]-OXAZOL-5(6H)-ONE
4,5-DIHYDRO[1,2,5]OXADIAZOLO[3,4-F]CINNOLIN-3-IUM-3-OLATE
6-(4H-1,2,4-triazol-4-yl)pyridine-2-carboxylic acid(SALTDATA: FREE)
Ethyl 3-amino-1H-pyrrole-2-carboxylate hydrochloride
1-(2-METHYLAMINOPROPYL)-3-ADAMANTANOLHYDROCHLORIDE
2H-Benzimidazole-2-thione,1,3-dihydro-1-(2-propenyl)-(9CI)
6-(4-FLUOROPHENYL)-3(2H)-PYRIDAZINONE
C10H7FN2O (190.05423839999997)
3-(4-fluorophenyl)-1H-pyrazole-4-carbaldehyde
C10H7FN2O (190.05423839999997)
3-METHYL-4-METHYLENE-3,4-DIHYDROQUINAZOLINE-2(1H)-THIONE
1-(4-FLUOROPHENYL)-1H-PYRAZOLE-4-CARBALDEHYDE
C10H7FN2O (190.05423839999997)
1-(3-NITRO-2-PYRIDINYL)-2-PYRROLIDINECARBOXYLICACID
3-(3-Fluorophenyl)-1H-pyrazole-4-carboxaldehyde
C10H7FN2O (190.05423839999997)
5-FLUORO-2-PHENYLPYRIMIDIN-4(3H)-ONE
C10H7FN2O (190.05423839999997)
Methyl 4-deoxy-alpha-L-threo-hex-4-enopyranosiduronic acid
5-(2-fluoropyridin-3-yl)-1H-pyrrole-3-carbaldehyde
C10H7FN2O (190.05423839999997)
3-fluoro-4-pyrazol-1-ylbenzaldehyde
C10H7FN2O (190.05423839999997)
[3-(Difluoromethyl)-5-methyl-1H-pyrazol-1-yl]-acetic acid
2-FLUORO-4-(1H-PYRAZOL-1-YL)BENZALDEHYDE
C10H7FN2O (190.05423839999997)
2-Hydroxy-2-methylpropane-1,2,3-tricarboxylic acid
2-(4-Fluorophenyl)-4(3H)-pyrimidinone
C10H7FN2O (190.05423839999997)
6-Oxo-4-(3-fluorophenyl)-1,6-dihydropyrimidine
C10H7FN2O (190.05423839999997)
(5-Hydroxyindol-3-yl)acetate
The indol-3-yl carboxylic acid anion formed by loss of a proton from the carboxy group of (5-hydroxyindol-3-yl)acetic acid; principal microspecies at pH 7.3
1,4,5-Trihydroxy-5-hydroxymethyl-cyclohex-1-en-3-one
3-Oxido-4,5-dihydro-[1,2,5]oxadiazolo[3,4-f]cinnolin-3-ium
N-acetyl-D-methionine(1-)
A D-alpha-amino acid anion resulting from the removal of the proton from the carboxy group of N-acetyl-D-methionine.
Carglumic Acid
A - Alimentary tract and metabolism > A16 - Other alimentary tract and metabolism products > A16A - Other alimentary tract and metabolism products > A16AA - Amino acids and derivatives C78275 - Agent Affecting Blood or Body Fluid
3-Dehydroquinic acid
A 4-oxo monocarboxylic acid derived from quinic acid by oxidation of the hydroxy group at position 3 to the corresponding keto group.
N-carbamoylglutamic acid
A glutamic acid derivative that is glutamic acid substituted by a carbamoyl group at the nitrogen atom.
1,3,4-Trihydroxy-5-oxocyclohexane-1-carboxylic acid
2-hydroxy-(indol-3-yl)acetate
An indol-3-yl carboxylic acid anion resulting from the deprotonation of the carboxy group of 2-hydroxy-(indol-3-yl)acetic acid. This is a very minor tautomer; the major tautomer is the corresponding oxindole.
N-acetyl-L-methionine(1-)
An L-alpha-amino acid anion that is the conjugate base of N-acetyl-L-methionine, obtgained by deprotonation of the carboxy group.